Archives

by in
Entry Author Date Location
Cardiac Dimensions Wins EU Approval for Heart Failure Device, Aims for Market in 2012 09/29/11 Seattle
Valeritas Raises $150M for Insulin Device 09/13/11 New York
Theraclone Snaps Up $10.6M Financing 09/08/11 Seattle
Theraclone Sciences Secures $10,600,000 Series B Round 09/08/11 Seattle
BuyWithMe Gets Edhance, LogMeIn Picks Up Pachube, Polaris Backs Two MA Companies, & More Boston-Area Deals News 07/20/11 Boston
Nevro Raises $58M for Anti-Pain Device 07/20/11 San Francisco
Nevro Lands $58,000,000 New Financing 07/20/11 San Francisco
Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News 07/15/11 Boston
Verastem, Rooted at MIT, Raises $32 Million and Adds ATV and Astellas to Slate of Investors 07/14/11 Boston
Verastem Obtains $32,000,000 Series B Financing Round 07/14/11 Boston
Allozyne Looks to Rustle Up Interest on Wall Street With Backdoor IPO 07/13/11 Seattle
Termeer Joins Verastem Board 06/13/11 Boston
Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing 05/24/11 Boston
23andMe Brings Down the Price of Consumer Genetic Tests, Builds Up Relations With Big Pharma 05/24/11 San Francisco
Radius Health Obtains $91,000,000 New Funding 05/24/11 Boston
Pacira Raises Wall Street Expectations of a New Blockbuster Painkiller 05/19/11 New York
iPierian, Stem Cell Startup With Big Science & Big Bucks, Axes Group of Top Executives 05/13/11 San Francisco
BayBio’s Annual Conference, Tweet by Tweet 04/22/11 San Francisco
Zacharon Aligns with Pfizer, Conatus Raises Big Bucks, Software Veteran Wins Wireless Institute Challenge, & More San Diego Life Sciences News 04/14/11 San Diego
The New Tech Bubble, Biotech Vs. Big Pharma, and More Thoughts from Boston BD Conference 04/14/11 Boston
Conatus Adds $7.5M, Closes Series B Round 04/13/11 San Diego
Conatus Pharmaceuticals Secures $7,500,000 Series B Financing 04/13/11 San Diego
Genzyme-Spinout Peptimmune Files for Chapter 7 Liquidation 03/23/11 Boston
Patients’ Parents Upset By FDA Panel’s Rejection of Lilly/Alnara’s Cystic Fibrosis Drug 01/19/11 Boston
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections 01/18/11 Seattle
Allozyne Passes First Clinical Trial, Dreams Big About a Once-Monthly Multiple Sclerosis Drug 01/10/11 Seattle
23andMe Adds $9M to VC Round 01/07/11 San Francisco
23andMe Secures $9,000,000 Series C Financing Round 01/07/11 San Francisco
Syndax Pharma Study Offers Clues that Lung Cancer Treatment Could Benefit Subset of Patients 12/10/10 Boston
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
Page 2 of 7 « previous page · next page »